SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-24-030748
Filing Date
2024-03-05
Accepted
2024-03-05 07:00:14
Documents
6
Period of Report
2024-03-04

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm243532-1_pre14a.htm PRE 14A 262169
2 GRAPHIC lg_jaguarhealth-4c.jpg GRAPHIC 33453
3 GRAPHIC px_jaguarproxy1pg01-bw.jpg GRAPHIC 190356
4 GRAPHIC px_jaguarproxy1pg02-bw.jpg GRAPHIC 297660
5 GRAPHIC px_jaguarproxy1pg03-bw.jpg GRAPHIC 384318
6 GRAPHIC sg_lisaaconte-bw.jpg GRAPHIC 12258
  Complete submission text file 0001104659-24-030748.txt   1445696
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36714 | Film No.: 24718230
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)